{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:01:22Z","timestamp":1792789282503,"version":"4.5.0"},"reference-count":206,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Public Health"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jiph.2025.103058","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T11:57:42Z","timestamp":1763639862000},"page":"103058","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Effective alternative strategies to combat challenges associated with MDR bacterial infections: Drug repurposing, role of artificial intelligence, and novel therapeutic options"],"prefix":"10.1016","volume":"19","author":[{"given":"Sayed E.","family":"El-Sayed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albeir A.","family":"Messiha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4507-376X","authenticated-orcid":false,"given":"Mai","family":"Zafer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jiph.2025.103058_bib1","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s44307-025-00059-7","article-title":"An alternative approach to combat multidrug-resistant bacteria: new insights into traditional Chinese medicine monomers combined with antibiotics","volume":"3","author":"Dai","year":"2025","journal-title":"Adv Biotechnol"},{"issue":"1","key":"10.1016\/j.jiph.2025.103058_bib2","doi-asserted-by":"crossref","first-page":"80","DOI":"10.54660\/.IJFMR.2025.6.1.80-93","article-title":"Innovative strategies for reducing antimicrobial resistance: a review of global policy and practice","volume":"6","author":"Kolawole","year":"2023","journal-title":"J Front Multidiscip Res"},{"issue":"1","key":"10.1016\/j.jiph.2025.103058_bib3","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S1473-3099(18)30605-4","article-title":"Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modeling analysis","volume":"19","author":"Cassini","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.jiph.2025.103058_bib4","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1093\/cid\/cix346","article-title":"Evaluating the clinical burden and mortality attributable to antibiotic resistance: the disparity of empirical data and simple model estimations","volume":"65","author":"Abat","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"1645","key":"10.1016\/j.jiph.2025.103058_bib5","doi-asserted-by":"crossref","first-page":"20130426","DOI":"10.1098\/rstb.2013.0426","article-title":"After 2015: infectious diseases in a new era of health and development","volume":"369","author":"Dye","year":"2014","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1016\/j.jiph.2025.103058_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108550","article-title":"Multitarget antibacterial drugs: an effective strategy to combat bacterial resistance","author":"Feng","year":"2023","journal-title":"Pharm Ther"},{"issue":"7","key":"10.1016\/j.jiph.2025.103058_bib7","first-page":"1079","article-title":"Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE","volume":"46","author":"Rice","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"29","key":"10.1016\/j.jiph.2025.103058_bib8","doi-asserted-by":"crossref","first-page":"14734","DOI":"10.1073\/pnas.1906169116","article-title":"Epistasis between antibiotic tolerance, persistence, and resistance mutations","volume":"116","author":"Levin-Reisman","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1016\/j.jiph.2025.103058_bib9","article-title":"Environment, animals, and food as reservoirs of antibiotic-resistant bacteria for humans: one health or more?","volume":"54","author":"Martak","year":"2024","journal-title":"Infect Dis Now"},{"key":"10.1016\/j.jiph.2025.103058_bib10","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/5250040","article-title":"Recent approaches for downplaying antibiotic resistance: molecular mechanisms","volume":"2023","author":"Ahmed","year":"2023","journal-title":"Biomed Res Int"},{"issue":"5","key":"10.1016\/j.jiph.2025.103058_bib11","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02095-19","article-title":"Antibiotics: combating tolerance to stop resistance","volume":"10","author":"Windels","year":"2019","journal-title":"mBio"},{"issue":"2","key":"10.1016\/j.jiph.2025.103058_bib12","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00354-17","article-title":"Tolerant, growing cells from nutrient shifts are not persister cells","volume":"8","author":"Kim","year":"2017","journal-title":"mBio"},{"issue":"4","key":"10.1016\/j.jiph.2025.103058_bib13","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.synbio.2025.07.001","article-title":"Extracellular vesicles enhance the efficacy of ceftiofur against intracellular bacterial infections","volume":"10","author":"Yuan","year":"2025","journal-title":"Synth Syst Biotechnol"},{"issue":"12","key":"10.1016\/j.jiph.2025.103058_bib14","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.3390\/pharmaceutics16121542","article-title":"Antimicrobial peptides: a promising solution to the rising threat of antibiotic resistance","volume":"16","author":"Islam","year":"2024","journal-title":"Pharmaceutics"},{"issue":"13","key":"10.1016\/j.jiph.2025.103058_bib15","doi-asserted-by":"crossref","first-page":"5193","DOI":"10.1007\/s00253-019-09785-0","article-title":"A recombinant fungal defensin-like peptide-P2 combats multidrug-resistant Staphylococcus aureus and biofilms","volume":"103","author":"Yang","year":"2019","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1016\/j.jiph.2025.103058_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111686","article-title":"Two optimized antimicrobial peptides with therapeutic potential for clinical antibiotic-resistant Staphylococcus aureus","volume":"183","author":"Li","year":"2019","journal-title":"Eur J Med Chem"},{"issue":"5","key":"10.1016\/j.jiph.2025.103058_bib17","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1021\/acsinfecdis.9b00164","article-title":"Antagonizing vancomycin resistance in Enterococcus by surface localized antimicrobial display-derived peptides","volume":"6","author":"Liu","year":"2020","journal-title":"ACS Infect Dis"},{"issue":"3","key":"10.1016\/j.jiph.2025.103058_bib18","doi-asserted-by":"crossref","first-page":"248","DOI":"10.2174\/138920310791112048","article-title":"EST-database search of plant defensins: an example using sugarcane, a large and complex genome","volume":"11","author":"Belarmino","year":"2010","journal-title":"Curr Protein Pept Sci"},{"issue":"19","key":"10.1016\/j.jiph.2025.103058_bib19","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.1039\/D1TB02757C","article-title":"Recent advances in the design of antimicrobial peptide conjugates","volume":"10","author":"Silva","year":"2022","journal-title":"J Mater Chem B"},{"issue":"1","key":"10.1016\/j.jiph.2025.103058_bib20","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1038\/s41598-018-19752-w","article-title":"AmPEP: sequence-based prediction of antimicrobial peptides using distribution patterns of amino acid properties and random forest","volume":"8","author":"Bhadra","year":"2018","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.jiph.2025.103058_bib21","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nrd3591","article-title":"Designing antimicrobial peptides: form follows function","volume":"11","author":"Fjell","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jiph.2025.103058_bib22","doi-asserted-by":"crossref","first-page":"D774","DOI":"10.1093\/nar\/gkp1021","article-title":"CAMP: a useful resource for research on antimicrobial peptides","volume":"38","author":"Thomas","year":"2010","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"10.1016\/j.jiph.2025.103058_bib23","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ab.2013.01.019","article-title":"iAMP-2L: a two-level multi-label classifier for identifying antimicrobial peptides and their functional types","volume":"436","author":"Xiao","year":"2013","journal-title":"Anal Biochem"},{"issue":"7","key":"10.1016\/j.jiph.2025.103058_bib24","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.febslet.2011.03.008","article-title":"Peptide promiscuity: an evolutionary concept for plant defense","volume":"585","author":"Franco","year":"2011","journal-title":"FEBS Lett"},{"issue":"6","key":"10.1016\/j.jiph.2025.103058_bib25","doi-asserted-by":"crossref","first-page":"773","DOI":"10.3390\/pharmaceutics13060773","article-title":"Challenge in the discovery of new drugs: antimicrobial peptides against WHO-list of critical and high-priority bacteria","volume":"13","author":"Roque-Borda","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jiph.2025.103058_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.micres.2024.127822","article-title":"Antimicrobial peptides: opportunities and challenges in overcoming resistance","volume":"286","author":"Bucataru","year":"2024","journal-title":"Microbiol Res"},{"issue":"20","key":"10.1016\/j.jiph.2025.103058_bib27","doi-asserted-by":"crossref","first-page":"9145","DOI":"10.1007\/s00253-013-5185-2","article-title":"Z)-4-bromo-5-(bromomethylene)-3-methylfuran-2(5H)-one sensitizes Escherichia coli persister cells to antibiotics","volume":"97","author":"Pan","year":"2013","journal-title":"Appl Microbiol Biotechnol"},{"issue":"7476","key":"10.1016\/j.jiph.2025.103058_bib28","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/nature12790","article-title":"Activated ClpP kills persisters and eradicates a chronic biofilm infection","volume":"503","author":"Conlon","year":"2013","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.jiph.2025.103058_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004321","article-title":"Identification of anti-virulence compounds that disrupt quorum-sensing regulated acute and persistent pathogenicity","volume":"10","author":"Starkey","year":"2014","journal-title":"PLoS Pathog"},{"issue":"6415","key":"10.1016\/j.jiph.2025.103058_bib30","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1126\/science.aar7981","article-title":"Heterogeneity in efflux pump expression predisposes antibiotic-resistant cells to mutation","volume":"362","author":"El Meouche","year":"2018","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.jiph.2025.103058_bib31","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.3390\/ph16121638","article-title":"Phage therapy\u2014challenges, opportunities and future prospects","volume":"16","author":"Zalewska-Pi\u0105tek","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.jiph.2025.103058_bib32","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ebiom.2015.12.023","article-title":"Oral phage therapy of acute bacterial diarrhea with two coliphage preparations: a randomized trial in children from Bangladesh","volume":"4","author":"Sarker","year":"2016","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.jiph.2025.103058_bib33","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.chom.2017.06.018","article-title":"Synergy between the host immune system and bacteriophage is essential for successful phage therapy against an acute respiratory pathogen","volume":"22","author":"Roach","year":"2017","journal-title":"Cell Host Microbe"},{"issue":"3","key":"10.1016\/j.jiph.2025.103058_bib34","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3390\/antibiotics8030131","article-title":"Phage therapy with a focus on the human microbiota","volume":"8","author":"Divya Ganeshan","year":"2019","journal-title":"Antibiot (Basel)"},{"issue":"10","key":"10.1016\/j.jiph.2025.103058_bib35","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1021\/acsinfecdis.5c00651","article-title":"Characterization and antimicrobial efficacy of a bacteriophage targeting multidrug-resistant Escherichia coli","volume":"11","author":"Xiao","year":"2025","journal-title":"ACS Infect Dis"},{"issue":"10","key":"10.1016\/j.jiph.2025.103058_bib36","doi-asserted-by":"crossref","first-page":"e00954","DOI":"10.1128\/AAC.00954-17","article-title":"Development and use of personalized bacteriophage-based therapeutic cocktails to treat a patient with a disseminated resistant Acinetobacter baumannii infection","volume":"61","author":"Schooley","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"issue":"Pt 11","key":"10.1016\/j.jiph.2025.103058_bib37","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1099\/jmm.0.029744-0","article-title":"Bacteriophage therapy for refractory Pseudomonas aeruginosa urinary tract infection","volume":"60","author":"Khawaldeh","year":"2011","journal-title":"J Med Microbiol"},{"issue":"9","key":"10.1016\/j.jiph.2025.103058_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0106628","article-title":"A window of opportunity to control the bacterial pathogen Pseudomonas aeruginosa, combining antibiotics and phages","volume":"9","author":"Torres-Barcel\u00f3","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jiph.2025.103058_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0168615","article-title":"Synergy and order effects of antibiotics and phages in killing Pseudomonas aeruginosa biofilms","volume":"12","author":"Chaudhry","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jiph.2025.103058_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41426-018-0169-z","article-title":"The disparate effects of bacteriophages on antibiotic-resistant bacteria","volume":"7","author":"Torres-Barcel\u00f3","year":"2018","journal-title":"Emerg Microbes Infect"},{"issue":"1","key":"10.1016\/j.jiph.2025.103058_bib41","doi-asserted-by":"crossref","DOI":"10.1038\/srep26717","article-title":"Phage selection restores antibiotic sensitivity in MDR Pseudomonas aeruginosa","volume":"6","author":"Chan","year":"2016","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.jiph.2025.103058_bib42","doi-asserted-by":"crossref","first-page":"556","DOI":"10.3390\/microorganisms7110556","article-title":"Combined use of the Ab105-2\u03c6\u0394CI lytic mutant phage and different antibiotics in clinical isolates of multi-resistant Acinetobacter baumannii","volume":"7","author":"Blasco","year":"2019","journal-title":"Microorganisms"},{"issue":"1","key":"10.1016\/j.jiph.2025.103058_bib43","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1574-6968.2006.00483.x","article-title":"Lysis of staphylococcal mastitis pathogens by bacteriophage phi11 endolysin","volume":"265","author":"Donovan","year":"2006","journal-title":"FEMS Microbiol Lett"},{"issue":"1","key":"10.1016\/j.jiph.2025.103058_bib44","article-title":"Bacteriophage-derived peptidase CHAP(K) eliminates and prevents staphylococcal biofilms","volume":"2013","author":"Fenton","year":"2013","journal-title":"Int J Microbiol"},{"issue":"8","key":"10.1016\/j.jiph.2025.103058_bib45","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1093\/jac\/dkt104","article-title":"Rapid degradation of Streptococcus pyogenes biofilms by PlyC, a bacteriophage-encoded endolysin","volume":"68","author":"Shen","year":"2013","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"10.1016\/j.jiph.2025.103058_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0192507","article-title":"In vitro characterization of PlyE146, a novel phage lysin that targets Gram-negative bacteria","volume":"13","author":"Larpin","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jiph.2025.103058_bib47","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-11832-7","article-title":"Highly potent antimicrobial modified peptides derived from the Acinetobacter baumannii phage endolysin LysAB2","volume":"7","author":"Peng","year":"2017","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.jiph.2025.103058_bib48","first-page":"1","article-title":"A randomized, placebo-controlled, double-blind clinical trial of bacteriophage cocktails in chronic wound infections","volume":"23","author":"Karn","year":"2024","journal-title":"Int J Low Extrem Wounds"},{"issue":"6","key":"10.1016\/j.jiph.2025.103058_bib49","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1038\/s41564-024-01705-x","article-title":"Personalized bacteriophage therapy outcomes for 100 consecutive cases: a multicentre, multinational, retrospective observational study","volume":"9","author":"Pirnay","year":"2024","journal-title":"Nat Microbiol"},{"issue":"1","key":"10.1016\/j.jiph.2025.103058_bib50","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1186\/s13063-022-07047-5","article-title":"Safety and microbiological activity of phage therapy in persons with cystic fibrosis colonized with Pseudomonas aeruginosa: study protocol for a phase 1b\/2, multicenter, randomized, double-blind, placebo-controlled trial","volume":"23","author":"Tamma","year":"2022","journal-title":"Trials"},{"issue":"18","key":"10.1016\/j.jiph.2025.103058_bib51","doi-asserted-by":"crossref","first-page":"14311","DOI":"10.3390\/ijms241814311","article-title":"Recent advances in bacterial persistence mechanisms","volume":"24","author":"Pan","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.jiph.2025.103058_bib52","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.3390\/molecules27061857","article-title":"Limitations of phage therapy and corresponding optimization strategies: a review","volume":"27","author":"Lin","year":"2022","journal-title":"Molecules"},{"issue":"14","key":"10.1016\/j.jiph.2025.103058_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e34849","article-title":"Mini review: advantages and limitations of lytic phages compared with chemical antibiotics to combat bacterial infections","volume":"10","author":"Guo","year":"2024","journal-title":"Heliyon"},{"issue":"7699","key":"10.1016\/j.jiph.2025.103058_bib54","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nature26157","article-title":"A new class of synthetic retinoid antibiotics effective against bacterial persisters","volume":"556","author":"Kim","year":"2018","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jiph.2025.103058_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1021\/cr400126u","article-title":"Functions, therapeutic applications, and synthesis of retinoids and carotenoids","volume":"114","author":"Alvarez","year":"2014","journal-title":"Chem Rev"},{"key":"10.1016\/j.jiph.2025.103058_bib56","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1397602","article-title":"Improving the treatment of bacterial infections caused by multidrug-resistant bacteria through drug repositioning","volume":"15","author":"Glajzner","year":"2024","journal-title":"Front Pharm"},{"issue":"2","key":"10.1016\/j.jiph.2025.103058_bib57","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1134\/S1068162023020139","article-title":"Drug repurposing: an effective tool in modern drug discovery","volume":"49","author":"Kulkarni","year":"2023","journal-title":"Russ J Bioorg Chem"},{"issue":"1","key":"10.1016\/j.jiph.2025.103058_bib58","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s12325-019-01144-9","article-title":"Ibuprofen safety at the golden anniversary: are all NSAIDs the same? A narrative review","volume":"37","author":"Varrassi","year":"2020","journal-title":"Adv Ther"},{"issue":"12","key":"10.1016\/j.jiph.2025.103058_bib59","first-page":"1441","article-title":"In silico validation of the non-antibiotic drugs acetaminophen and ibuprofen as antibacterial agents against red complex pathogens","volume":"90","author":"Vijayashree Priyadharsini","year":"2019","journal-title":"J Periodo"},{"key":"10.1016\/j.jiph.2025.103058_bib60","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ejps.2015.02.011","article-title":"Antimicrobial activity of ibuprofen: new perspectives on an \u201cold\u201d non-antibiotic drug","volume":"71","author":"Obad","year":"2015","journal-title":"Eur J Pharm Sci"},{"issue":"13","key":"10.1016\/j.jiph.2025.103058_bib61","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.2174\/1389557520666200505124922","article-title":"Anticancer and antimicrobial activities of naproxen and naproxen derivatives","volume":"20","author":"Han","year":"2020","journal-title":"Mini Rev Med Chem"},{"issue":"3","key":"10.1016\/j.jiph.2025.103058_bib62","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01574-17","article-title":"Antimicrobial activity of ibuprofen against cystic fibrosis-associated Gram-negative pathogens","volume":"62","author":"Shah","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.jiph.2025.103058_bib63","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3390\/jof6010005","article-title":"Candida spp.\/bacteria mixed biofilms","volume":"6","author":"Rodrigues","year":"2019","journal-title":"J Fungi (Basel)"},{"issue":"5","key":"10.1016\/j.jiph.2025.103058_bib64","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.bmc.2016.01.026","article-title":"In vitro interactions between anidulafungin and nonsteroidal anti-inflammatory drugs on biofilms of Candida spp","volume":"24","author":"Rosato","year":"2016","journal-title":"Bioorg Med Chem"},{"issue":"6","key":"10.1016\/j.jiph.2025.103058_bib65","doi-asserted-by":"crossref","first-page":"688","DOI":"10.3390\/antibiotics10060688","article-title":"Synergistic activity of new diclofenac and essential oil combinations against different Candida spp","volume":"10","author":"Rosato","year":"2021","journal-title":"Antibiot (Basel)"},{"issue":"7","key":"10.1016\/j.jiph.2025.103058_bib66","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.joen.2021.04.004","article-title":"Antibiofilm activity of diclofenac and antibiotic solutions in endodontic therapy","volume":"47","author":"Ferrer-Luque","year":"2021","journal-title":"J Endod"},{"key":"10.1016\/j.jiph.2025.103058_bib67","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.chemosphere.2018.07.034","article-title":"The combined toxicity of UV\/chlorinated products from binary ibuprofen (IBP) and tyrosine (Tyr) on Escherichia coli: emphasis on their occurrence and underlying mechanism","volume":"210","author":"Chen","year":"2018","journal-title":"Chemosphere"},{"key":"10.1016\/j.jiph.2025.103058_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.carres.2019.107891","article-title":"Antibacterial effects and ibuprofen release potential using chitosan microspheres loaded with silver nanoparticles","volume":"488","author":"Pereira","year":"2020","journal-title":"Carbohydr Res"},{"issue":"1","key":"10.1016\/j.jiph.2025.103058_bib69","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/s42003-019-0530-3","article-title":"Cyclooxygenase inhibitors impair CD4 T cell immunity and exacerbate Mycobacterium tuberculosis infection in aerosol-challenged mice","volume":"2","author":"Mortensen","year":"2019","journal-title":"Commun Biol"},{"issue":"7","key":"10.1016\/j.jiph.2025.103058_bib70","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1128\/IAI.00076-11","article-title":"Estradiol and progesterone strongly inhibit the innate immune response of mononuclear cells in newborns","volume":"79","author":"Giannoni","year":"2011","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.jiph.2025.103058_bib71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1043-6618(05)80058-1","article-title":"Lipocortin and vasocortin: two species of anti-inflammatory proteins mimicking the effects of glucocorticoids","volume":"25","author":"Sautebin","year":"1992","journal-title":"Pharm Res"},{"issue":"4","key":"10.1016\/j.jiph.2025.103058_bib72","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1080\/00016480510027529","article-title":"External otitis caused by infection with Pseudomonas aeruginosa or Candida albicans cured by use of a topical group III steroid, without any antibiotics","volume":"125","author":"Emg\u00e5rd","year":"2005","journal-title":"Acta Otolaryngol"},{"key":"10.1016\/j.jiph.2025.103058_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2019.103847","article-title":"Antimicrobial activities of peptide Cbf-K16 against drug-resistant Helicobacter pylori infection in vitro and in vivo","volume":"138","author":"Jiang","year":"2020","journal-title":"Micro Pathog"},{"issue":"3","key":"10.1016\/j.jiph.2025.103058_bib74","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ijantimicag.2009.10.011","article-title":"Inhibition of Listeria monocytogenes infection by neurological drugs","volume":"35","author":"Lieberman","year":"2010","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"10.1016\/j.jiph.2025.103058_bib75","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0924-8579(02)00110-3","article-title":"Intracellular activity of clinical concentrations of phenothiazines including thioridazine against phagocytosed Staphylococcus aureus","volume":"20","author":"Ordway","year":"2002","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"10.1016\/j.jiph.2025.103058_bib76","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ijantimicag.2009.02.015","article-title":"In vitro activity of thioridazine against mycobacteria","volume":"34","author":"van Ingen","year":"2009","journal-title":"Int J Antimicrob Agents"},{"issue":"6","key":"10.1016\/j.jiph.2025.103058_bib77","doi-asserted-by":"crossref","first-page":"731","DOI":"10.2174\/1389450116666150806124110","article-title":"New antimicrobial approaches: reuse of old drugs","volume":"17","author":"Savoia","year":"2016","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.jiph.2025.103058_bib78","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1007\/s10096-011-1435-3","article-title":"Evidence of significant synergism between antibiotics and the antipsychotic, antimicrobial drug flupenthixol","volume":"31","author":"Jeyaseeli","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"9","key":"10.1016\/j.jiph.2025.103058_bib79","doi-asserted-by":"crossref","first-page":"915","DOI":"10.3390\/ph14090915","article-title":"Antimicrobial properties of antidepressants and antipsychotics\u2014possibilities and implications","volume":"14","author":"Caldara","year":"2021","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10.1016\/j.jiph.2025.103058_bib80","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40709-015-0028-1","article-title":"Sertraline enhances the activity of antimicrobial agents against pathogens of clinical relevance","volume":"22","author":"Ayaz","year":"2015","journal-title":"J Biol Res (Thessal)"},{"issue":"1","key":"10.1016\/j.jiph.2025.103058_bib81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.20510\/ukjpb\/6\/i1\/173522","article-title":"Study on antimicrobial potential of selected non-antibiotics and their interaction with conventional antibiotics","volume":"6","author":"Hadera","year":"2018","journal-title":"Pharm Biosci J"},{"key":"10.1016\/j.jiph.2025.103058_bib82","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.micpath.2018.07.040","article-title":"New roles of fluoxetine in pharmacology: antibacterial effect and modulation of antibiotic activity","volume":"123","author":"de Sousa","year":"2018","journal-title":"Micro Pathog"},{"key":"10.1016\/j.jiph.2025.103058_bib83","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s00044-019-02470-x","article-title":"In vitro evaluation of the antibacterial activity of amitriptyline and its synergistic effect with ciprofloxacin, sulfamethoxazole\u2013trimethoprim, and colistin as an alternative in drug repositioning","volume":"29","author":"de","year":"2020","journal-title":"Med Chem Res"},{"issue":"3","key":"10.1016\/j.jiph.2025.103058_bib84","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3390\/antibiotics9030107","article-title":"Antimicrobial properties of non-antibiotic drugs in the era of increased bacterial resistance","volume":"9","author":"Lagadinou","year":"2020","journal-title":"Antibiot (Basel)"},{"issue":"7","key":"10.1016\/j.jiph.2025.103058_bib85","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00181-20","article-title":"Thioridazine is an efflux pump inhibitor in Mycobacterium avium complex but of limited clinical relevance","volume":"64","author":"Ruth","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.jiph.2025.103058_bib86","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-74752-z","article-title":"Anti-staphylococcal activity and mode of action of thioridazine photoproducts","volume":"10","author":"Tozar","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jiph.2025.103058_bib87","article-title":"Thioridazine induces cardiotoxicity via reactive oxygen species-mediated hERG channel deficiency and L-type calcium channel activation","volume":"2020","author":"Liu","year":"2020","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.jiph.2025.103058_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2020.114961","article-title":"A systematic strategy for estimating hERG block potency and its implications in a new cardiac safety paradigm","volume":"394","author":"Ridder","year":"2020","journal-title":"Toxicol Appl Pharm"},{"issue":"4","key":"10.1016\/j.jiph.2025.103058_bib89","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124595","article-title":"Repurposing salicylanilide anthelmintic drugs to combat drug-resistant Staphylococcus aureus","volume":"10","author":"Rajamuthiah","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jiph.2025.103058_bib90","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1128\/AAC.01952-12","article-title":"New life for an old drug: the anthelmintic drug niclosamide inhibits Pseudomonas aeruginosa quorum sensing","volume":"57","author":"Imperi","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiph.2025.103058_bib91","doi-asserted-by":"crossref","first-page":"348","DOI":"10.3389\/fcimb.2018.00348","article-title":"Synergistic activity of niclosamide in combination with colistin against colistin-susceptible and colistin-resistant Acinetobacter baumannii and Klebsiella pneumoniae","volume":"8","author":"Ayerbe-Algaba","year":"2018","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"10.1016\/j.jiph.2025.103058_bib92","doi-asserted-by":"crossref","DOI":"10.1038\/srep33642","article-title":"Reprofiled anthelmintics abate hypervirulent stationary-phase Clostridium difficile","volume":"6","author":"Gooyit","year":"2016","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.jiph.2025.103058_bib93","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003549","article-title":"In vitro activity of avermectins against Mycobacterium ulcerans","volume":"9","author":"Omansen","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.jiph.2025.103058_bib94","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13756-018-0314-4","article-title":"In vitro activity of ivermectin against Staphylococcus aureus clinical isolates","volume":"7","author":"Ashraf","year":"2018","journal-title":"Antimicrob Resist Infect Control"},{"issue":"11","key":"10.1016\/j.jiph.2025.103058_bib95","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1007\/s00011-008-8007-8","article-title":"Ivermectin inhibits LPS-induced production of inflammatory cytokines and improves LPS-induced survival in mice","volume":"57","author":"Zhang","year":"2008","journal-title":"Inflamm Res"},{"key":"10.1016\/j.jiph.2025.103058_bib96","doi-asserted-by":"crossref","first-page":"438","DOI":"10.3389\/fcimb.2018.00438","article-title":"Repurposing screen identifies unconventional drugs with activity against multidrug-resistant Acinetobacter baumannii","volume":"8","author":"Cheng","year":"2018","journal-title":"Front Cell Infect Microbiol"},{"issue":"460","key":"10.1016\/j.jiph.2025.103058_bib97","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aat7520","article-title":"Gallium disrupts bacterial iron metabolism and has therapeutic effects in mice and humans with lung infections","volume":"10","author":"Goss","year":"2018","journal-title":"Sci Transl Med"},{"issue":"11","key":"10.1016\/j.jiph.2025.103058_bib98","doi-asserted-by":"crossref","first-page":"4406","DOI":"10.1111\/1462-2920.12873","article-title":"Combatting bacterial infections by killing persister cells with mitomycin C","volume":"17","author":"Kwan","year":"2015","journal-title":"Environ Microbiol"},{"issue":"9","key":"10.1016\/j.jiph.2025.103058_bib99","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1002\/bit.25963","article-title":"DNA-crosslinker cisplatin eradicates bacterial persister cells","volume":"113","author":"Chowdhury","year":"2016","journal-title":"Biotechnol Bioeng"},{"issue":"35","key":"10.1016\/j.jiph.2025.103058_bib100","doi-asserted-by":"crossref","first-page":"11048","DOI":"10.1073\/pnas.1511751112","article-title":"Antagonism screen for inhibitors of bacterial cell wall biogenesis uncovers an inhibitor of undecaprenyl diphosphate synthase","volume":"112","author":"Farha","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10.1016\/j.jiph.2025.103058_bib101","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/jac\/dkm496","article-title":"Unexpected antimicrobial effect of statins","volume":"61","author":"Jerwood","year":"2008","journal-title":"J Antimicrob Chemother"},{"issue":"5A","key":"10.1016\/j.jiph.2025.103058_bib102","doi-asserted-by":"crossref","first-page":"28B","DOI":"10.1016\/S0002-9149(01)01454-0","article-title":"Preclinical and clinical pharmacology of rosuvastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor","volume":"87","author":"McTaggart","year":"2001","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.1016\/j.jiph.2025.103058_bib103","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0128098","article-title":"Statins and antimicrobial effects: simvastatin as a potential drug against Staphylococcus aureus biofilm","volume":"10","author":"Graziano","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jiph.2025.103058_bib104","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3389\/fmicb.2019.00041","article-title":"Drug repurposing for the treatment of bacterial and fungal infections","volume":"10","author":"Mir\u00f3-Canturri","year":"2019","journal-title":"Front Microbiol"},{"issue":"1","key":"10.1016\/j.jiph.2025.103058_bib105","doi-asserted-by":"crossref","DOI":"10.1038\/srep16407","article-title":"Exploring simvastatin, an antihyperlipidemic drug, as a potential topical antibacterial agent","volume":"5","author":"Thangamani","year":"2015","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.jiph.2025.103058_bib106","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1007\/s10096-018-3227-5","article-title":"In vitro antibacterial effects of statins against bacterial pathogens causing skin infections","volume":"37","author":"Ko","year":"2018","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jiph.2025.103058_bib107","doi-asserted-by":"crossref","first-page":"8","DOI":"10.33393\/dti.2024.3019","article-title":"The dark side of drug repurposing: from clinical trial challenges to antimicrobial resistance","volume":"18","author":"Natsheh","year":"2024","journal-title":"Drug Target Insights"},{"key":"10.1016\/j.jiph.2025.103058_bib108","doi-asserted-by":"crossref","first-page":"5229","DOI":"10.2147\/IDR.S494327","article-title":"CRISPR-Cas systems in the fight against antimicrobial resistance: current status, potentials, and future directions","volume":"17","author":"Ahmed","year":"2024","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.jiph.2025.103058_bib109","doi-asserted-by":"crossref","unstructured":"Owaid H.A., Al-Ouqaili M.T., Al-Marzooq F. Genomic approach to studying the relationship between the CRISPR\/Cas system and multidrug resistance in clinical isolates of Klebsiella pneumoniae. bioRxiv 2024;2024.09.11.612500. https:\/\/doi.org\/10.1101\/2024.09.11.612500.","DOI":"10.1101\/2024.09.11.612500"},{"key":"10.1016\/j.jiph.2025.103058_bib110","doi-asserted-by":"crossref","DOI":"10.1016\/j.jgar.2025.04.022","article-title":"Investigating the prevalence of CRISPR-Cas system and their association with antibiotic resistance genes and virulence factors in Enterococcus faecalis and Enterococcus faecium strains isolated from hospitalized patients","author":"Soltani","year":"2025","journal-title":"J Glob Antimicrob Resist"},{"issue":"3","key":"10.1016\/j.jiph.2025.103058_bib111","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3390\/pharmaceutics13030352","article-title":"Novel strategy to combat antibiotic resistance: a sight into the combination of CRISPR\/Cas9 and nanoparticles","volume":"13","author":"Wan","year":"2021","journal-title":"Pharmaceutics"},{"issue":"5","key":"10.1016\/j.jiph.2025.103058_bib112","doi-asserted-by":"crossref","first-page":"954","DOI":"10.3390\/microorganisms9050954","article-title":"Cracking the challenge of antimicrobial drug resistance with CRISPR\/Cas9, nanotechnology, and other strategies in ESKAPE pathogens","volume":"9","author":"Zohra","year":"2021","journal-title":"Microorganisms"},{"issue":"11","key":"10.1016\/j.jiph.2025.103058_bib113","doi-asserted-by":"crossref","first-page":"6072","DOI":"10.3390\/ijms22116072","article-title":"CRISPR\/Cas9: principle, applications, and delivery through extracellular vesicles","volume":"22","author":"Horodecka","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jiph.2025.103058_bib114","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.716064","article-title":"Harnessing the CRISPR-Cas systems to combat antimicrobial resistance","volume":"12","author":"Duan","year":"2021","journal-title":"Front Microbiol"},{"issue":"7","key":"10.1016\/j.jiph.2025.103058_bib115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009672","article-title":"CRISPR-based antimicrobials to obstruct antibiotic-resistant and pathogenic bacteria","volume":"17","author":"Palacios Araya","year":"2021","journal-title":"PLoS Pathog"},{"issue":"10","key":"10.1016\/j.jiph.2025.103058_bib116","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.addr.2005.04.002","article-title":"Bacterial resistance to antibiotics: enzymatic degradation and modification","volume":"57","author":"Wright","year":"2005","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"10.1016\/j.jiph.2025.103058_bib117","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1038\/s41467-023-37789-y","article-title":"Associate toxin\u2013antitoxin with CRISPR-Cas to kill multidrug-resistant pathogens","volume":"14","author":"Wang","year":"2023","journal-title":"Nat Commun"},{"issue":"7","key":"10.1016\/j.jiph.2025.103058_bib118","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1021\/acsinfecdis.2c00649","article-title":"CRISPR-Cas-based antimicrobials: design, challenges, and bacterial mechanisms of resistance","volume":"9","author":"Mayorga-Ramos","year":"2023","journal-title":"ACS Infect Dis"},{"issue":"2","key":"10.1016\/j.jiph.2025.103058_bib119","first-page":"246","article-title":"Monoclonal antibodies as a therapeutic strategy against multidrug-resistant bacterial infections in a post-COVID-19 era","volume":"14","author":"Chen","year":"2024","journal-title":"Life (Basel)"},{"issue":"1","key":"10.1016\/j.jiph.2025.103058_bib120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12929-019-0592-z","article-title":"Development of therapeutic antibodies for the treatment of diseases","volume":"27","author":"Lu","year":"2020","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.jiph.2025.103058_bib121","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jgar.2020.12.025","article-title":"Exploring the future of infectious disease treatment in a post-antibiotic era: a comparative review of alternative therapeutics","volume":"24","author":"Streicher","year":"2021","journal-title":"J Glob Antimicrob Resist"},{"issue":"1","key":"10.1016\/j.jiph.2025.103058_bib122","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3390\/antibiotics12010067","article-title":"Current promising strategies against antibiotic-resistant bacterial infections","volume":"12","author":"Ye","year":"2022","journal-title":"Antibiot (Basel)"},{"issue":"3","key":"10.1016\/j.jiph.2025.103058_bib123","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01991-21","article-title":"Analysis of the clinical pipeline of treatments for drug-resistant bacterial infections: despite progress, more action is needed","volume":"66","author":"Butler","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.jiph.2025.103058_bib124","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/s41579-020-00506-3","article-title":"The role of vaccines in combating antimicrobial resistance","volume":"19","author":"Micoli","year":"2021","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"10.1016\/j.jiph.2025.103058_bib125","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4161\/hv.34306","article-title":"Hepatitis B vaccination: are escape mutant viruses a matter of concern?","volume":"11","author":"Roman\u00f2","year":"2015","journal-title":"Hum Vaccin Immunother"},{"issue":"5","key":"10.1016\/j.jiph.2025.103058_bib126","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41579-022-00820-y","article-title":"Molecular mechanisms of antibiotic resistance revisited","volume":"21","author":"Darby","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.jiph.2025.103058_bib127","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2024.108492","article-title":"Current innovations in mRNA vaccines for targeting multidrug-resistant ESKAPE pathogens","volume":"79","author":"Imani","year":"2025","journal-title":"Biotechnol Adv"},{"issue":"1","key":"10.1016\/j.jiph.2025.103058_bib128","doi-asserted-by":"crossref","first-page":"113","DOI":"10.4103\/abr.abr_92_24","article-title":"Antimicrobial feature of nanoparticles in the antibiotic resistance era: from mechanism to application","volume":"13","author":"Salmani-Zarchi","year":"2024","journal-title":"Adv Biomed Res"},{"issue":"6","key":"10.1016\/j.jiph.2025.103058_bib129","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nrmicro3028","article-title":"Antimicrobial activity of metals: mechanisms, molecular targets and applications","volume":"11","author":"Lemire","year":"2013","journal-title":"Nat Rev Microbiol"},{"issue":"7","key":"10.1016\/j.jiph.2025.103058_bib130","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1016\/j.biomaterials.2011.11.057","article-title":"The molecular mechanism of action of bactericidal gold nanoparticles on Escherichia coli","volume":"33","author":"Cui","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.jiph.2025.103058_bib131","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1476-0711-11-13","article-title":"Antibacterial activity of statins: a comparative study of atorvastatin, simvastatin, and rosuvastatin","volume":"11","author":"Masadeh","year":"2012","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"4","key":"10.1016\/j.jiph.2025.103058_bib132","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000053","article-title":"Global transcriptome and deletome profiles of yeast exposed to transition metals","volume":"4","author":"Jin","year":"2008","journal-title":"PLoS Genet"},{"issue":"4","key":"10.1016\/j.jiph.2025.103058_bib133","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3","article-title":"A mechanistic study of the antibacterial effect of silver ions on Escherichia coli and Staphylococcus aureus","volume":"52","author":"Feng","year":"2000","journal-title":"J Biomed Mater Res"},{"issue":"45","key":"10.1016\/j.jiph.2025.103058_bib134","doi-asserted-by":"crossref","first-page":"33568","DOI":"10.1039\/D4RA06117A","article-title":"Nanomedicines as a cutting-edge solution to combat antimicrobial resistance","volume":"14","author":"Solanki","year":"2024","journal-title":"RSC Adv"},{"key":"10.1016\/j.jiph.2025.103058_bib135","series-title":"Nanoparticles in Pharmacotherapy","first-page":"485","article-title":"Microbially synthesized nanoparticles as next generation antimicrobials: scope and applications","author":"Busi","year":"2019"},{"key":"10.1016\/j.jiph.2025.103058_bib136","doi-asserted-by":"crossref","DOI":"10.1016\/j.inoche.2022.109590","article-title":"Different antibacterial and photocatalyst functions for herbal and bacterial synthesized silver and copper\/copper oxide nanoparticles\/nanocomposites: a review","volume":"142","author":"Alavi","year":"2022","journal-title":"Inorg Chem Commun"},{"key":"10.1016\/j.jiph.2025.103058_bib137","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.mimet.2019.02.010","article-title":"Revisiting the mechanistic pathways for bacterial-mediated synthesis of noble metal nanoparticles","volume":"159","author":"Ali","year":"2019","journal-title":"J Microbiol Methods"},{"issue":"12","key":"10.1016\/j.jiph.2025.103058_bib138","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.3390\/molecules24122303","article-title":"Green synthesis of silver nanoparticles with culture supernatant of a bacterium Pseudomonas rhodesiae and their antibacterial activity against soft rot pathogen Dickeya dadantii","volume":"24","author":"Hossain","year":"2019","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.jiph.2025.103058_bib139","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1038\/s41598-018-22112-3","article-title":"Green synthesis of gold nanoparticles by thermophilic filamentous fungi","volume":"8","author":"Moln\u00e1r","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jiph.2025.103058_bib140","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s00253-009-2032-6","article-title":"Lactic acid bacteria as reducing and capping agent for the fast and efficient production of silver nanoparticles","volume":"84","author":"Sintubin","year":"2009","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1016\/j.jiph.2025.103058_bib141","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.colsurfa.2013.09.034","article-title":"Biogenic synthesis of antimicrobial silver nanoparticles capped with L-cysteine","volume":"460","author":"Perni","year":"2014","journal-title":"Colloids Surf A Physicochem Eng Asp"},{"key":"10.1016\/j.jiph.2025.103058_bib142","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1477-3155-3-8","article-title":"Mechanistic aspects of biosynthesis of silver nanoparticles by several Fusarium oxysporum strains","volume":"3","author":"Dur\u00e1n","year":"2005","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.jiph.2025.103058_bib143","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s10529-006-9256-7","article-title":"Nitrate reductase-mediated synthesis of silver nanoparticles from AgNO\u2083","volume":"29","author":"Anil Kumar","year":"2007","journal-title":"Biotechnol Lett"},{"issue":"2","key":"10.1016\/j.jiph.2025.103058_bib144","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ijantimicag.2013.11.002","article-title":"Nanoparticles and the control of oral infections","volume":"43","author":"Allaker","year":"2014","journal-title":"Int J Antimicrob Agents"},{"issue":"7","key":"10.1016\/j.jiph.2025.103058_bib145","article-title":"A milk extracellular vesicle-based nanoplatform enhances combination therapy against multidrug-resistant bacterial infections","volume":"12","author":"Qu","year":"2025","journal-title":"Adv Sci (Weinh)"},{"issue":"4","key":"10.1016\/j.jiph.2025.103058_bib146","article-title":"Nanoparticles-induced potential toxicity on human health: applications, toxicity mechanisms, and evaluation models","volume":"4","author":"Xuan","year":"2023","journal-title":"MedComm (2020)"},{"key":"10.1016\/j.jiph.2025.103058_bib147","first-page":"0083","article-title":"Nanoparticles for drug delivery: insight into in vitro and in vivo drug release from nanomedicines","volume":"10","author":"Ewii","year":"2025","journal-title":"Nano TransMed"},{"issue":"12","key":"10.1016\/j.jiph.2025.103058_bib148","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.1016\/j.xphs.2024.09.005","article-title":"Current state of nanomedicine drug products: an industry perspective","volume":"113","author":"Clogston","year":"2024","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.jiph.2025.103058_bib149","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113768","article-title":"Molecular hybrids: a five-year survey on structures of multiple targeted hybrids of protein kinase inhibitors for cancer therapy","volume":"225","author":"Soltan","year":"2021","journal-title":"Eur J Med Chem"},{"issue":"6","key":"10.1016\/j.jiph.2025.103058_bib150","doi-asserted-by":"crossref","first-page":"587","DOI":"10.2174\/138161209787315594","article-title":"Designing multiple ligands: medicinal chemistry strategies and challenges","volume":"15","author":"Morphy","year":"2009","journal-title":"Curr Pharm Des"},{"issue":"12","key":"10.1016\/j.jiph.2025.103058_bib151","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.tips.2015.08.010","article-title":"Polypharmacology shakes hands with complex aetiopathology","volume":"36","author":"Brodie","year":"2015","journal-title":"Trends Pharm Sci"},{"key":"10.1016\/j.jiph.2025.103058_bib152","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.106055","article-title":"Polypharmacology: the science of multi-targeting molecules","volume":"176","author":"Kabir","year":"2022","journal-title":"Pharm Res"},{"key":"10.1016\/j.jiph.2025.103058_bib153","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.2147\/DDDT.S257494","article-title":"Potential impact of the multi-target drug approach in the treatment of some complex diseases","volume":"14","author":"Makhoba","year":"2020","journal-title":"Drug Des Devel Ther"},{"issue":"13","key":"10.1016\/j.jiph.2025.103058_bib154","doi-asserted-by":"crossref","first-page":"3732","DOI":"10.1016\/j.bmcl.2013.05.011","article-title":"Synthesis and biological evaluation of sorafenib- and regorafenib-like sEH inhibitors","volume":"23","author":"Hwang","year":"2013","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.jiph.2025.103058_bib155","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/9781118098141.ch8","article-title":"Polypharmacological kinase inhibitors: new hopes for cancer therapy. In","author":"Petrelli","year":"2012","journal-title":"Polypharmacology Drug Discov"},{"issue":"6","key":"10.1016\/j.jiph.2025.103058_bib156","doi-asserted-by":"crossref","first-page":"726","DOI":"10.2174\/1570159X16666180315141643","article-title":"Changing paradigm from one target one ligand towards multi-target directed ligand design for key drug targets of Alzheimer disease: an important role of in silico methods in multi-target directed ligands design","volume":"16","author":"Kumar","year":"2018","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.jiph.2025.103058_bib157","first-page":"109","article-title":"History, current situation, and future perspectives on antibiotics and antibiotic resistance","volume":"2","author":"Dyary","year":"2023","journal-title":"Int J Agric Biosci"},{"issue":"11","key":"10.1016\/j.jiph.2025.103058_bib158","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0165737","article-title":"The human kinome targeted by FDA approved multi-target drugs and combination products: a comparative study from the drug-target interaction network perspective","volume":"11","author":"Li","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jiph.2025.103058_bib159","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/9781118098141.ch9","article-title":"Polypharmacology as an emerging trend in antibacterial discovery. In","author":"Silver","year":"2012","journal-title":"Polypharmacology Drug Discov"},{"key":"10.1016\/j.jiph.2025.103058_bib160","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.832750","article-title":"Autophagy\u2013inflammation interplay during infection: balancing pathogen clearance and host inflammation","volume":"13","author":"Pang","year":"2022","journal-title":"Front Pharm"},{"issue":"14","key":"10.1016\/j.jiph.2025.103058_bib161","doi-asserted-by":"crossref","first-page":"7688","DOI":"10.3390\/ijms22147688","article-title":"Roles of PRR-mediated signaling pathways in the regulation of oxidative stress and inflammatory diseases","volume":"22","author":"Li","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"9","key":"10.1016\/j.jiph.2025.103058_bib162","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1093\/infdis\/jir522","article-title":"Toll-like receptor 2 mediates fatal immunopathology in mice during treatment of secondary pneumococcal pneumonia following influenza","volume":"204","author":"Karlstr\u00f6m","year":"2011","journal-title":"J Infect Dis"},{"issue":"15","key":"10.1016\/j.jiph.2025.103058_bib163","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1001\/archinte.161.15.1837","article-title":"Monotherapy may be suboptimal for severe bacteremic pneumococcal pneumonia","volume":"161","author":"Waterer","year":"2001","journal-title":"Arch Intern Med"},{"issue":"4","key":"10.1016\/j.jiph.2025.103058_bib164","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1086\/367541","article-title":"Addition of a macrolide to a \u03b2-lactam-based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia","volume":"36","author":"Mart\u00ednez","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.jiph.2025.103058_bib165","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1164\/rccm.200311-1578OC","article-title":"Combination antibiotic therapy lowers mortality among severely ill patients with pneumococcal bacteremia","volume":"170","author":"Baddour","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"10.1016\/j.jiph.2025.103058_bib166","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1093\/infdis\/jiu823","article-title":"Sphingosine-1-phosphate receptor agonism reduces Bordetella pertussis\u2013mediated lung pathology","volume":"211","author":"Skerry","year":"2015","journal-title":"J Infect Dis"},{"issue":"12","key":"10.1016\/j.jiph.2025.103058_bib167","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1038\/nbt1266","article-title":"New antibiotics from bacterial natural products","volume":"24","author":"Clardy","year":"2006","journal-title":"Nat Biotechnol"},{"issue":"1","key":"10.1016\/j.jiph.2025.103058_bib168","doi-asserted-by":"crossref","DOI":"10.1080\/20565623.2024.2430452","article-title":"Biologically active metabolites of Alcaligenes faecalis: diversity, statistical optimization, and future perspectives","volume":"10","author":"El-Sayed","year":"2024","journal-title":"Future Sci OA"},{"issue":"1","key":"10.1016\/j.jiph.2025.103058_bib169","doi-asserted-by":"crossref","DOI":"10.1186\/s43141-021-00156-9","article-title":"Secondary metabolites and biodiversity of actinomycetes","volume":"19","author":"Selim","year":"2021","journal-title":"J Genet Eng Biotechnol"},{"issue":"1","key":"10.1016\/j.jiph.2025.103058_bib170","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1146\/annurev.mi.39.100185.001541","article-title":"Measurement of in situ activities of nonphotosynthetic microorganisms in aquatic and terrestrial habitats","volume":"39","author":"Staley","year":"1985","journal-title":"Annu Rev Microbiol"},{"issue":"8","key":"10.1016\/j.jiph.2025.103058_bib171","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/ja.2010.87","article-title":"Uncultured microorganisms as a source of secondary metabolites","volume":"63","author":"Lewis","year":"2010","journal-title":"J Antibiot"},{"issue":"12","key":"10.1016\/j.jiph.2025.103058_bib172","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.3390\/microorganisms11122835","article-title":"Identification, characterization, and production optimization of 6-methoxy-1H-indole-2-carboxylic acid antifungal metabolite produced by Bacillus toyonensis isolate OQ071612","volume":"11","author":"El-Sayed","year":"2023","journal-title":"Microorganisms"},{"issue":"5570","key":"10.1016\/j.jiph.2025.103058_bib173","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1126\/science.1070633","article-title":"Isolating \u201cuncultivable\u201d microorganisms in pure culture in a simulated natural environment","volume":"296","author":"Kaeberlein","year":"2002","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.jiph.2025.103058_bib174","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.copbio.2005.10.001","article-title":"Recent developments towards the heterologous expression of complex bacterial natural product biosynthetic pathways","volume":"16","author":"Wenzel","year":"2005","journal-title":"Curr Opin Biotechnol"},{"issue":"7","key":"10.1016\/j.jiph.2025.103058_bib175","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.tibtech.2004.04.006","article-title":"Codon bias and heterologous protein expression","volume":"22","author":"Gustafsson","year":"2004","journal-title":"Trends Biotechnol"},{"issue":"11","key":"10.1016\/j.jiph.2025.103058_bib176","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S1074-5521(96)90181-7","article-title":"A new enzyme superfamily\u2014the phosphopantetheinyl transferases","volume":"3","author":"Lambalot","year":"1996","journal-title":"Chem Biol"},{"key":"10.1016\/j.jiph.2025.103058_bib177","article-title":"Synergistic antimicrobial efficacy of glabrol and colistin through micelle-based co-delivery against multidrug-resistant bacterial pathogens","volume":"137156371","author":"Liu","year":"2025","journal-title":"Phytomedicine"},{"issue":"1","key":"10.1016\/j.jiph.2025.103058_bib178","first-page":"272","article-title":"Enhancing antimicrobial resistance strategies: leveraging artificial intelligence for improved outcomes","volume":"51","author":"Mohammed","year":"2025","journal-title":"S Afr J Chem Eng"},{"issue":"6","key":"10.1016\/j.jiph.2025.103058_bib179","doi-asserted-by":"crossref","first-page":"502","DOI":"10.3390\/antibiotics13060502","article-title":"Implications of artificial intelligence in addressing antimicrobial resistance: innovations, global challenges, and healthcare\u2019s future","volume":"13","author":"Branda","year":"2024","journal-title":"Antibiotics"},{"issue":"2","key":"10.1016\/j.jiph.2025.103058_bib180","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3390\/antibiotics14020134","article-title":"The role of artificial intelligence and machine learning models in antimicrobial stewardship in public health: a narrative review","volume":"14","author":"Pennisi","year":"2025","journal-title":"Antibiot (Basel)"},{"key":"10.1016\/j.jiph.2025.103058_bib181","first-page":"189","article-title":"Artificial intelligence in combating antimicrobial resistance","volume":"10","author":"Natto","year":"2024","journal-title":"IP Int J Med Microbiol Trop Dis"},{"issue":"14","key":"10.1016\/j.jiph.2025.103058_bib182","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.1016\/j.cell.2024.05.013","article-title":"Discovery of antimicrobial peptides in the global microbiome with machine learning","volume":"187","author":"Santos-J\u00fanior","year":"2024","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.jiph.2025.103058_bib183","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41746-024-01400-5","article-title":"AI-driven decision support reduces antibiotic mismatches and inappropriate use in outpatient urinary tract infections","volume":"8","author":"Shapiro Ben David","year":"2025","journal-title":"NPJ Digit Med"},{"issue":"1","key":"10.1016\/j.jiph.2025.103058_bib184","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s43856-024-00606-8","article-title":"Predicting future hospital antimicrobial resistance prevalence using machine learning","volume":"4","author":"Vihta","year":"2024","journal-title":"Commun Med (Lond)"},{"issue":"1","key":"10.1016\/j.jiph.2025.103058_bib185","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s10916-024-02089-5","article-title":"From data to decisions: leveraging artificial intelligence and machine learning in combating antimicrobial resistance\u2013a comprehensive review","volume":"48","author":"de la Lastra","year":"2024","journal-title":"J Med Syst"},{"key":"10.1016\/j.jiph.2025.103058_bib186","article-title":"Future-proofing healthcare: artificial intelligence (AI) strategies for antimicrobial resistance (AMR) management","volume":"447","author":"Hayfa","year":"2025","journal-title":"Bact Enemies Hum Health"},{"issue":"5","key":"10.1016\/j.jiph.2025.103058_bib187","doi-asserted-by":"crossref","first-page":"443","DOI":"10.4155\/fmc-2018-0329","article-title":"Photoinactivation of ESKAPE pathogens: overview of novel therapeutic strategy","volume":"11","author":"Nakonieczna","year":"2019","journal-title":"Future Med Chem"},{"issue":"13","key":"10.1016\/j.jiph.2025.103058_bib188","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1128\/AEM.00756-16","article-title":"Antibacterial activity of blue light against nosocomial wound pathogens growing planktonically and as mature biofilms","volume":"82","author":"Halstead","year":"2016","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.jiph.2025.103058_bib189","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.737635","article-title":"Non-thermal plasma treatment of ESKAPE pathogens: a review","volume":"12","author":"Scholtz","year":"2021","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jiph.2025.103058_bib190","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.foodcont.2016.12.021","article-title":"Inactivation mechanisms of non-thermal plasma on microbes: a review","volume":"75","author":"Liao","year":"2017","journal-title":"Food Control"},{"key":"10.1016\/j.jiph.2025.103058_bib191","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.tifs.2018.05.007","article-title":"Plasma-activated water (PAW): chemistry, physico-chemical properties, applications in food and agriculture","volume":"77","author":"Thirumdas","year":"2018","journal-title":"Trends Food Sci Technol"},{"issue":"1","key":"10.1016\/j.jiph.2025.103058_bib192","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.nano.2009.04.006","article-title":"Biogenic synthesis of silver nanoparticles and their synergistic effect with antibiotics: a study against Gram-positive and Gram-negative bacteria","volume":"6","author":"Fayaz","year":"2010","journal-title":"Nanomedicine"},{"issue":"1","key":"10.1016\/j.jiph.2025.103058_bib193","first-page":"132","article-title":"Synergistic effect of biogenic silver nanoparticles with \u03b2-lactam cefotaxime against resistant Staphylococcus arlettae AUMC b-163 isolated from T3A pharmaceutical cleanroom, Assiut, Egypt","volume":"4","author":"Hassan","year":"2016","journal-title":"Am J Microbiol Res"},{"issue":"12","key":"10.1016\/j.jiph.2025.103058_bib194","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1099\/jmm.0.047100-0","article-title":"Synergistic effects between silver nanoparticles and antibiotics and the mechanisms involved","volume":"61","author":"Hwang","year":"2012","journal-title":"J Med Microbiol"},{"issue":"1","key":"10.1016\/j.jiph.2025.103058_bib195","article-title":"Comparative study on the synergistic action of differentially synthesized silver nanoparticles with \u03b2-cephem antibiotics and chloramphenicol","volume":"2014","author":"Hari","year":"2014","journal-title":"J Nanosci"},{"issue":"7","key":"10.1016\/j.jiph.2025.103058_bib196","doi-asserted-by":"crossref","first-page":"452","DOI":"10.4236\/oje.2016.67043","article-title":"Synergistic effect of silver nanoparticles with neomycin or gentamicin antibiotics on mastitis-causing Staphylococcus aureus","volume":"6","author":"Jamaran","year":"2016","journal-title":"Open J Ecol"},{"issue":"12","key":"10.1016\/j.jiph.2025.103058_bib197","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1007\/s11671-007-9104-2","article-title":"In vitro structural and functional evaluation of gold nanoparticle\u2013conjugated antibiotics","volume":"2","author":"Saha","year":"2007","journal-title":"Nanoscale Res Lett"},{"issue":"32","key":"10.1016\/j.jiph.2025.103058_bib198","doi-asserted-by":"crossref","first-page":"6789","DOI":"10.1039\/c0jm00817f","article-title":"Antibiotic-mediated synthesis of gold nanoparticles with potent antimicrobial activity and their application in antimicrobial coatings","volume":"20","author":"Rai","year":"2010","journal-title":"J Mater Chem"},{"issue":"1","key":"10.1016\/j.jiph.2025.103058_bib199","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1166\/jbn.2013.1472","article-title":"Selectively enhanced antibacterial effects and ultraviolet activation of antibiotics with ZnO nanorods against Escherichia coli","volume":"9","author":"Luo","year":"2013","journal-title":"J Biomed Nanotechnol"},{"issue":"2","key":"10.1016\/j.jiph.2025.103058_bib200","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/jbm.b.31615","article-title":"ZnO nanoparticles enhanced antibacterial activity of ciprofloxacin against Staphylococcus aureus and Escherichia coli","volume":"93","author":"Banoee","year":"2010","journal-title":"J Biomed Mater Res B Appl Biomater"},{"key":"10.1016\/j.jiph.2025.103058_bib201","first-page":"64","article-title":"Nanostructured zinc oxide enhances the activity of antibiotics against Staphylococcus aureus","volume":"1","author":"Venubabu Thati","year":"2010","journal-title":"J Biosci Technol"},{"issue":"1","key":"10.1016\/j.jiph.2025.103058_bib202","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4236\/jbnb.2010.11005","article-title":"Effect of nano-titanium dioxide with different antibiotics against methicillin-resistant Staphylococcus aureus","volume":"1","author":"Roy","year":"2010","journal-title":"J Biomater Nanobiotechnol"},{"issue":"11","key":"10.1016\/j.jiph.2025.103058_bib203","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1080\/17458080.2016.1177216","article-title":"Copper nanoparticles catalysed an efficient one-pot multicomponent synthesis of chromene derivatives and its antibacterial activity","volume":"11","author":"Tanna","year":"2016","journal-title":"J Exp Nanosci"},{"key":"10.1016\/j.jiph.2025.103058_bib204","first-page":"387","article-title":"Synergistic effects of bismuth nanoparticles along with antibiotics on PKS-positive Klebsiella pneumoniae isolates from colorectal cancer patients; comparison with quinolone antibiotics","volume":"3","author":"Tarjoman","year":"2015","journal-title":"Res J Med Med Sci"},{"issue":"1","key":"10.1016\/j.jiph.2025.103058_bib205","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1007\/s11051-012-1413-4","article-title":"Enhanced synergism of antibiotics with zinc oxide nanoparticles against extended-spectrum \u03b2-lactamase producers implicated in urinary tract infections","volume":"15","author":"Bhande","year":"2013","journal-title":"J Nanopart Res"},{"issue":"2","key":"10.1016\/j.jiph.2025.103058_bib206","doi-asserted-by":"crossref","first-page":"352","DOI":"10.2741\/e827","article-title":"Nanoantibiotics: future nanotechnologies to combat antibiotic resistance","volume":"10","author":"Muzammil","year":"2018","journal-title":"Front Biosci"}],"container-title":["Journal of Infection and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034125004071?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034125004071?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T08:39:27Z","timestamp":1768811967000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876034125004071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":206,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S1876034125004071"],"URL":"https:\/\/doi.org\/10.1016\/j.jiph.2025.103058","relation":{},"ISSN":["1876-0341"],"issn-type":[{"value":"1876-0341","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effective alternative strategies to combat challenges associated with MDR bacterial infections: Drug repurposing, role of artificial intelligence, and novel therapeutic options","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Public Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiph.2025.103058","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.","name":"copyright","label":"Copyright"}],"article-number":"103058"}}